NCT07233759
- Conditions
- Atezolizumab, Digestive System Diseases, Digestive System Neoplasms, +7 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan
Clinical trial condition
Digestive System Neoplasms
Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.
14,203 public trials
3,225 recruiting studies
Digestive System Neoplasms trial results
NCT05945901
- Conditions
- Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
- Locations
-
- Sun Yat-Sen University Cancer Center Guangzhou, Guangdog, China
Active, Not Recruiting
The DISSECT Study: Effect of Peri-aDventItial SMA diSsECtion on Margin sTatus During Pancreaticoduodenectomy for Resectable Pancreatic Cancer
NCT04902352
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
- Locations
-
- University Hospitals Birmingham NHS Foundation Trust Birmingham, County (Optional), United Kingdom
Active, Not Recruiting
Detect and Expunge Concealed Tumors of the Liver
NCT06141564
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Liver Cancer, +4 more
- Locations
-
- 108 Military Central Hospital Hanoi, Vietnam
Active, Not Recruiting
Colon Neoadjuvant FOLFOXIRI Study
NCT01941641
- Conditions
- Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
- Locations
-
- Department of Clinical Oncology Hong Kong
Active, Not Recruiting
A Study of Dostarlimab in Participants With Untreated Locally Advanced Rectal Cancer in China
NCT06640049
- Conditions
- Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
- Locations
-
- GSK Investigational Site Chengdu, China
- GSK Investigational Site Chongqing, China
- GSK Investigational Site Guangzhou, China
- GSK Investigational Site Guangzhou, China
Active, Not Recruiting
Sequential TACE-SBRT Combined With Targeted Immunotherapy for Patients With Intermediate to Advanced Liver Cancer
NCT07230080
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
- Locations
-
- Nanfang Hosptial Guangzhou, China
Active, Not Recruiting
Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression
NCT04180371
- Conditions
- Adnexal Diseases, Advanced Solid Tumor Historically Known for High EphA2 Expression, Breast Diseases, +49 more
- Locations
-
- California Cancer Associates for Research and Excellence, Inc. Encinitas, California, United States
- University of California - Irvine Medical Center Orange, California, United States
- Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
- Florida Cancer Specialists Sarasota, Florida, United States
Active, Not Recruiting
FOLFOXIRI With or Without Intensification for Rectal Cancer
NCT03997435
- Conditions
- Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
- Locations
-
- Department of Clinical Oncology, Queen Mary Hospital Hong Kong
- Department of Oncology, Princess Margaret Hospital Hong Kong
- The Chinese University of Hong Kong Hong Kong
Active, Not Recruiting
Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer
NCT02293954
- Conditions
- Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +59 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States